Amit Mookim leads Immuneel Therapeutics as Chief Executive Officer, advancing how cell and gene therapy in India can be scaled responsibly and made more accessible. His work focuses on translating complex scientific innovation into sustainable healthcare models that balance impact, affordability, and long-term system value.

Over the years, he has held senior leadership roles across healthcare strategy, market access, and transformation initiatives within global organisations and advisory environments. His experience reflects an ability to connect science, policy, and commercial execution while navigating evolving healthcare ecosystems.

Before Immuneel, Amit worked with organisations such as IQVIA and KPMG India, advising public and private stakeholders on large-scale healthcare challenges. This background shapes his approach to building purpose-led organisations that combine innovation with disciplined growth. Amit brings over two decades of experience across healthcare and life sciences and continues to contribute to advancing equitable access to advanced therapies.